Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

NCT06826157 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06826157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06826157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 5, 2021
Completion date
January 1, 2027
Enrollment
175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, frontotemporal dementia (ftd), healthy subjects, lewy body dementia (lbd), mild alzheimer disease, mild cognitive impairment (mci)